Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Gut microbiota and immune profiling of microbiota-humanised versus wildtype mouse models of hepatointestinal schistosomiasis.

Animal microbiome·2024
Same author

Pulmonary inflammation promoted by type-2 dendritic cells is a feature of human and murine schistosomiasis.

Nature communications·2023
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Abstracts of presentations to the Annual Meetings of the Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons Canadian Hepato-Pancreato-Biliary Society Canadian Society of Surgical Oncology Canadian Society of Colon and Rectal Surgeons: Victoria, BC Sept. 10-13, 2009.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Managing junctional haemorrhage in the combat environment.

BMJ military health·2020
Same author

Evaluation of a visual tool co-developed for training hospital staff on the prevention and control of the spread of healthcare associated infections.

Infection, disease & health·2019

相关实验视频

Updated: Jul 11, 2026

Preparation of Myeloid Derived Suppressor Cells (MDSC) from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting (AutoMACS)
14:15

Preparation of Myeloid Derived Suppressor Cells (MDSC) from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting (AutoMACS)

Published on: June 18, 2012

锡罗利木斯-塔克罗利木斯组合可以抑制免疫力.

V C McAlister, Z Gao, K Peltekian

    Lancet (London, England)
    |February 9, 2000
    PubMed
    概括

    接受 sirolimus 和低剂量 tacrolimus 的器官移植受体显示出低排斥率和良好的移植功能. 这种组合疗法被证明是有效和安全的,在肝脏,脏和胰腺移植患者中避免了显著的药物毒性.

    科学领域:

    • 腎臟病學 (nephrology) 是一種醫學專業.
    • 肝病学 肝病学是一种肝病学.
    • 移植手术 移植手术

    背景情况:

    • 器官移植后免疫抑制至关重要,以防止器官被排斥.
    • 像塔克罗利斯这样的氨酸抑制剂是标准的,但与毒性有关.
    • 需要新的免疫抑制策略来改善长期结果.

    研究的目的:

    • 评估西罗利斯与低剂量塔克罗利斯结合在移植受体中的疗效和安全性.
    • 评估这个患者队列中移植排斥率和移植功能.

    主要方法:

    • 对接受肝脏,脏或胰腺移植的32名患者进行了回顾性分析.
    • 患者接受了西罗和低剂量塔克罗的联合治疗.
    • 结果包括排斥率,移植功能和不良事件.

    主要成果:

    • 在研究小组中观察到急性排斥率较低.
    • 在整个随访期间都保持了优良的移植功能.
    • 没有报告与药物相关的显著毒性影响,这表明耐受性良好.

    结论:

    • 与低剂量塔克罗利斯结合的西洛利斯是肝脏,脏和胰腺移植接受者有效的免疫抑制疗法.

    更多相关视频

    Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
    07:49

    Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

    Published on: April 13, 2015

    Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
    08:41

    Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

    Published on: June 7, 2017

    相关实验视频

    Last Updated: Jul 11, 2026

    Preparation of Myeloid Derived Suppressor Cells (MDSC) from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting (AutoMACS)
    14:15

    Preparation of Myeloid Derived Suppressor Cells (MDSC) from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting (AutoMACS)

    Published on: June 18, 2012

    Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
    07:49

    Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

    Published on: April 13, 2015

    Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
    08:41

    Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

    Published on: June 7, 2017

  • 这种组合疗法提供了有利的安全性,毒性最小.
  • 这些发现支持使用这种疗法来改善移植结果.